{"abstract": "The pharmaceutical company, which sells a treatment for immune-related ailments at $28,000 a vial, bought a much cheaper alternative of the drug.", "web_url": "https://www.nytimes.com/2013/06/15/business/questcor-pays-135-million-for-rights-to-competitors-drug.html", "snippet": "The pharmaceutical company, which sells a treatment for immune-related ailments at $28,000 a vial, bought a much cheaper alternative of the drug.", "lead_paragraph": "A pharmaceutical company that has reaped huge profits by selling a 60-year-old drug for $28,000 a vial has eliminated the most obvious threat of competition from a much cheaper drug by acquiring the rights to it.", "print_section": "B", "print_page": "3", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2013/06/15/business/Quest/Quest-jumbo.jpg", "height": 681, "width": 454, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "superJumbo", "caption": null, "credit": null, "type": "image", "url": "images/2013/06/15/business/Quest/Quest-superJumbo.jpg", "height": 681, "width": 454, "subType": "superJumbo", "crop_name": "superJumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2013/06/15/business/Quest/Quest-thumbStandard.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2013/06/15/business/Quest/Quest-thumbStandard.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}, {"rank": 0, "subtype": "thumbLarge", "caption": null, "credit": null, "type": "image", "url": "images/2013/06/15/business/Quest/Quest-thumbLarge.jpg", "height": 150, "width": 150, "subType": "thumbLarge", "crop_name": "thumbLarge", "legacy": {}}], "headline": {"main": "Questcor Pays $135 Million to Acquire Rights to a Competitor\u2019s Drug", "kicker": null, "content_kicker": null, "print_headline": "Questcor Pays $135 Million to Acquire Rights to a Competitor\u2019s Drug", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "persons", "value": "Pollack, Andrew", "rank": 1, "major": "N"}, {"name": "subject", "value": "Acthar (Drug)", "rank": 2, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 3, "major": "N"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 4, "major": "N"}, {"name": "organizations", "value": "Questcor Pharmaceuticals Incorporated", "rank": 5, "major": "N"}, {"name": "organizations", "value": "Novartis AG", "rank": 6, "major": "N"}, {"name": "subject", "value": "Immune System", "rank": 7, "major": "N"}], "pub_date": "2013-06-14T21:51:00+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Andrew Pollack", "person": [{"firstname": "Andrew", "middlename": null, "lastname": "Pollack", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/4e05a1d8-43b1-56e3-99e6-14d4c59a5d4b", "word_count": 836, "uri": "nyt://article/4e05a1d8-43b1-56e3-99e6-14d4c59a5d4b"}